EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systemic Inflammation Response Index Predicts Thrombolytic Therapy Requirement in Intermediate-High Risk Acute Pulmonary Embolism: A Retrospective Study

Tuğba Çiçek iD, Kerim Yeşildağ iD

Journal of Clinical Medicine · 04.06.2026 · 15 (11) · 4362

DOI: 10.3390/jcm15114362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 04.06.2026. Verfasst von Tuğba Çiçek und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Diseases, Necmettin Erbakan University School of Medicine, 42090 Konya, Türkiye. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intermediate-high-risk acute pulmonary embolism (APE) presents a clinical challenge, as patients are hemodynamically stable at admission yet carry a substantial risk of deterioration requiring rescue thrombolytic therapy. This study evaluated whether admission complete blood count-derived inflammatory indices, particularly the Systemic Inflammation Response Index (SIRI), are associated with subsequent thrombolytic therapy requirement.

Methods

In this retrospective cohort study, 134 patients with computed tomography pulmonary angiography–confirmed intermediate-high-risk APE, classified according to 2019 ESC guidelines, were grouped based on the need for rescue thrombolytic therapy (n = 52) versus no thrombolytic therapy (n = 82). Inflammatory indices were calculated from admission blood samples, and multivariable logistic regression and ROC analyses were performed.

Results

Patients requiring thrombolysis had significantly higher SIRI, SII, hs-troponin I, and systolic pulmonary artery pressure (SPAP), and lower lymphocyte counts. In multivariable analysis, SIRI (OR = 2.08, 95% CI 1.37–3.13), SPAP (OR = 1.21, 95% CI 1.06–1.37), and troponin (OR = 1.01 per 10 ng/L increment, 95% CI 1.00–1.01) were independently associated with thrombolytic therapy requirement.

Conclusions

SIRI, SPAP, and hs-troponin I were independently associated with thrombolytic therapy requirement in intermediate-high-risk APE. These findings are hypothesis-generating and warrant prospective validation before clinical implementation.

Schlagwörter

Stichwörter der Autor:innen

acute pulmonary embolismbiomarkersimmunothrombosisrisk stratificationsystemic inflammation response indexthrombolytic therapy

Autor:innen und Institutionen

  • Department of Pulmonary Diseases, Necmettin Erbakan University School of Medicine, 42090 Konya, Türkiye.

ORCID-Profile: Tuğba Çiçek, Kerim Yeşildağ

Zitieren

APA

Çiçek, T., & Yeşildağ, K. (2026). Systemic Inflammation Response Index Predicts Thrombolytic Therapy Requirement in Intermediate-High Risk Acute Pulmonary Embolism: A Retrospective Study. Journal of Clinical Medicine, 15(11), 4362. https://doi.org/10.3390/jcm15114362

Vancouver

Çiçek T, Yeşildağ K. Systemic Inflammation Response Index Predicts Thrombolytic Therapy Requirement in Intermediate-High Risk Acute Pulmonary Embolism: A Retrospective Study. Journal of Clinical Medicine. 2026;15(11):4362. doi:10.3390/jcm15114362

BibTeX
@article{iek2026,
  author = {Çiçek, Tuğba and Yeşildağ, Kerim},
  title = {Systemic Inflammation Response Index Predicts Thrombolytic Therapy Requirement in Intermediate-High Risk Acute Pulmonary Embolism: A Retrospective Study},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {4362},
  doi = {10.3390/jcm15114362}
}
Kostenlos starten →